Analyst Ratings for Lexicon Pharmaceuticals (LXRX)

LXRX Rating Summary

LXRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LXRX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $8.50 (+99.5%) * Over Last 12-Mos
Rating Score: 2.7 / 10   Percentile Rank: 22%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/29/2021 Wedbush Liana Moussatos Downgrade Neutral
(Outperform)
8.00
(2.00)
8.06
(4.26)
-47.15% Details
1/29/2021 JPMorgan Jessica Fye Upgrade Neutral
(Underweight)
7.00
(N/A)
8.06
(4.26)
-47.15% Details